IRIS
MUSIANI, Piero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.801
EU - Europa 7.859
AS - Asia 6.910
SA - Sud America 741
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 14
Totale 26.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.603
SG - Singapore 2.468
CN - Cina 2.182
UA - Ucraina 1.457
RU - Federazione Russa 1.432
GB - Regno Unito 1.063
TR - Turchia 1.055
IE - Irlanda 1.031
SE - Svezia 769
FR - Francia 680
BR - Brasile 621
DE - Germania 504
VN - Vietnam 459
IT - Italia 435
IN - India 317
FI - Finlandia 292
BD - Bangladesh 129
CA - Canada 110
MX - Messico 51
HK - Hong Kong 44
AR - Argentina 40
IQ - Iraq 40
PL - Polonia 39
BE - Belgio 35
CZ - Repubblica Ceca 31
KR - Corea 30
JP - Giappone 28
ZA - Sudafrica 27
ES - Italia 26
PK - Pakistan 24
IL - Israele 20
VE - Venezuela 20
EU - Europa 19
GR - Grecia 18
SA - Arabia Saudita 18
MA - Marocco 15
EC - Ecuador 14
UZ - Uzbekistan 13
CO - Colombia 12
CL - Cile 11
JM - Giamaica 11
KE - Kenya 11
NL - Olanda 11
ID - Indonesia 10
IR - Iran 10
JO - Giordania 10
AU - Australia 9
AZ - Azerbaigian 9
LT - Lituania 9
PY - Paraguay 9
PH - Filippine 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
MY - Malesia 6
AT - Austria 5
DZ - Algeria 5
ET - Etiopia 5
NP - Nepal 5
OM - Oman 5
TN - Tunisia 5
UY - Uruguay 5
CR - Costa Rica 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PE - Perù 4
RO - Romania 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
GT - Guatemala 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
BH - Bahrain 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
NG - Nigeria 2
SY - Repubblica araba siriana 2
BB - Barbados 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
RW - Ruanda 1
SC - Seychelles 1
Totale 26.426
Salva come PNG Salva come JPEG
Città #
Singapore 1.689
Jacksonville 1.444
Chandler 1.250
San Jose 1.224
Dublin 1.026
Southend 818
Dallas 719
Ashburn 568
Izmir 523
Princeton 492
Nanjing 422
Beijing 421
Dearborn 421
Wilmington 346
Cambridge 257
Council Bluffs 251
Los Angeles 216
Tongling 213
New York 206
Ann Arbor 180
Buffalo 166
Ho Chi Minh City 148
Santa Clara 148
Nanchang 142
Boardman 139
Woodbridge 130
Grevenbroich 99
Hanoi 98
Moscow 97
The Dalles 95
Altamura 94
São Paulo 74
Houston 72
Hefei 71
Shenyang 71
Hebei 67
Tianjin 64
Chieti 58
Jiaxing 56
Kunming 51
Redondo Beach 51
Jinan 42
Hangzhou 41
Norwalk 41
Changsha 39
Orange 39
Toronto 39
Orem 38
Hong Kong 36
Warsaw 36
Augusta 35
San Mateo 35
Helsinki 34
Chennai 32
Chicago 32
Brussels 31
London 31
Brno 30
Munich 29
Seoul 29
Tokyo 27
Boston 26
Dong Ket 26
Milan 26
Grafing 24
Guangzhou 24
Manchester 23
Rome 23
Da Nang 22
Johannesburg 22
Montreal 22
Rio de Janeiro 22
Atlanta 21
Denver 21
San Francisco 21
Washington 21
Mexico City 20
Mumbai 20
Ottawa 20
Brooklyn 19
Romola 19
Andover 18
Ningbo 18
Phoenix 18
Auburn Hills 17
Frankfurt am Main 17
Leawood 17
Haiphong 15
Turku 14
Baghdad 13
Lanzhou 13
Seattle 13
Zhengzhou 13
Belo Horizonte 12
Curitiba 12
Stockholm 12
Tashkent 12
Changchun 11
Charlotte 11
Falls Church 11
Totale 16.082
Salva come PNG Salva come JPEG
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 1.258
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 246
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 190
Role of GM-CSF in cryptogenic organizing pneumonia 187
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 169
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 167
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 166
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 165
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 163
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 159
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 159
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 157
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 156
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 156
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 152
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 152
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 151
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 149
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 148
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 147
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 145
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 145
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 143
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 141
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 141
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 140
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 140
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 140
Carcinomi polmonari umani: produzione di TGFbeta1 138
T3 expression by human thymocytes in culture. 135
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 134
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 133
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 132
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 132
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 132
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 131
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 131
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 131
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 131
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 130
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 129
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 129
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 128
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 126
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 126
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 126
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 125
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 125
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. 125
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 125
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 124
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 123
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 123
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 122
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 122
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 120
Alpha-l-antitrypsin deficiency and human pathology. 120
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 120
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 119
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 118
Antimetastatic activity of a preventive cancer vaccine. 118
Neutrophils in anti-cancer immunological strategies: old players in new games 118
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 118
Alloantisera defining surface antigens on human thymocytes. 118
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 118
The Mutyh base excision repair gene influences the inflammatory response in a mouse model of ulcerative colitis. 118
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 118
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 117
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 117
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 117
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 117
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 117
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 116
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 116
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. 116
Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis. 116
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 116
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 116
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. 115
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 115
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 115
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 114
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 114
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 113
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 113
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 113
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth. 112
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 112
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 112
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 112
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 112
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 111
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 111
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 111
Immune cell characterization and cytokine detection in inflammatory bowel disease. 111
Proliferative capabilities of T3-positive thymocytes. 111
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 111
A human thymoma with prothymocyte-like infiltration. 110
Development of a murine orthotopic model of leukemia: evaluation of TP53 gene therapy efficacy. 110
Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene. 109
Totale 14.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022926 18 12 7 122 142 32 33 82 65 30 121 262
2022/20233.423 294 297 164 446 376 773 204 260 446 38 72 53
2023/20241.387 136 49 65 36 104 428 363 40 11 20 14 121
2024/20253.317 224 489 401 75 63 49 36 238 392 150 367 833
2025/20267.930 635 442 985 706 466 517 1.143 573 1.325 552 442 144
2026/202764 64 0 0 0 0 0 0 0 0 0 0 0
Totale 26.736